Siedlerstraße 7 | 68623 Lampertheim, Germany

info@zamann-pharma.com

Since QMSR took effect in February 2026, FDA inspectors can review internal audits and management reviews. Learn what FDA IVD guidance expects, from 510(k) pathways and analytical validation to labeling, LDT status and the Form 483 gaps investigators cite most.
IVD regulations now decide market access in both the EU and US. Learn how notified bodies test classification, performance evaluation and transition status, where IVDR and FDA requirements differ, and which compliance gaps auditors’ flag most often.
IVD registration under the EU IVDR demands more than paperwork. Discover how risk classification, performance evaluation, CE marking, and EUDAMED requirements shape market access, and learn the essential steps to avoid costly regulatory delays and certification setbacks.
Learn how ANVISA classifies medical devices, when notification or registration applies, and what manufacturers need for BGMP, local representation, technical documentation, and market access. This guide helps teams avoid common submission delays and plan a clearer regulatory pathway in Brazil.
Entering Saudi Arabia’s medical device market requires more than submitting an application. Explore SFDA classification, MDMA registration, authorized representative licensing, QMS evidence, inspection findings, and post-market obligations to understand what manufacturers need for compliant market access.
Entering South Korea’s medical device market requires more than a product dossier. Explore how risk classification, regulatory documentation, local representation, and quality-system requirements shape the approval pathway—and learn which steps can help prevent avoidable submission delays.
Planning medical device registration in Singapore? Discover how HSA risk classes, evaluation routes, ASEAN CSDT requirements, and dealer licences shape approval. Read our practical guide to avoid delays and understand your post-market responsibilities before entering the Singapore market.
Medical device registration in China requires careful planning from classification to approval. Discover how NMPA rules shape clinical evaluation, type testing, local agent responsibilities, and GMP compliance, plus practical steps to prevent registration delays and maintain compliance after launch.
Navigating medical device registration in India requires accurate risk classification, licensing documentation, and inspection readiness. Explore CDSCO requirements under the Medical Devices Rules 2017, including manufacturing approvals, import licensing, quality management obligations, and common compliance challenges manufacturers must address.
Learn how EU MDR requirements shape PMS plans, PSURs, PMCF, vigilance, trend reporting, and risk management across device classes. This guide explains practical reporting duties, evidence flows, and regulatory controls that help manufacturers maintain compliant, inspection-ready post-market systems.